HIV and Aging Research Reveals New Priorities for Extending Healthy Lifespan
International workshop identifies key strategies for managing aging challenges in HIV patients, with implications for broader longevity research.
Summary
The 15th Annual International Workshop on Aging and HIV brought together researchers to address the unique challenges faced by aging HIV patients. As HIV treatments have improved, patients are living longer but experiencing accelerated aging processes. The workshop identified critical research priorities including geroscience-informed clinical trials, better screening for frailty and cognitive decline, medication management strategies, and scalable care models. Key focus areas included understanding aging mechanisms in HIV, managing multiple medications, addressing cognitive impairment, and developing specialized care approaches for people who acquired HIV at birth and are now aging.
Detailed Summary
As HIV treatments have dramatically improved survival rates, a new challenge has emerged: HIV patients are experiencing accelerated aging processes that require specialized research and care approaches. The 15th Annual International Workshop on Aging and HIV addressed this critical intersection of longevity science and infectious disease management.
The workshop brought together interdisciplinary experts to examine how aging mechanisms interact with HIV infection. Researchers presented findings on clinical manifestations including frailty, neurocognitive impairment, and unique challenges faced by individuals with perinatally acquired HIV who are now reaching middle age. The event emphasized integrating geroscience principles into HIV research and clinical practice.
Key priorities identified include developing geroscience-informed clinical trials that target aging pathways in HIV patients, implementing systematic screening for frailty and cognitive decline, addressing polypharmacy through deprescribing strategies, and creating scalable geriatric-HIV care models. Special attention was given to career development in this emerging field.
For longevity research, this work provides insights into how chronic infections accelerate aging processes and how interventions might slow these effects. The focus on frailty screening, cognitive preservation, and medication optimization has broader applications for healthy aging. The integration of geroscience principles with clinical care offers a model for addressing age-related decline in various populations.
Limitations include the workshop format, which presents expert opinions and research directions rather than new experimental data. The findings represent consensus views from specialists rather than controlled studies, and implementation of proposed strategies requires further validation across diverse populations and healthcare settings.
Key Findings
- HIV patients experience accelerated aging requiring specialized geroscience-informed clinical trials
- Systematic frailty and cognitive screening needed for aging HIV populations
- Polypharmacy management through deprescribing strategies identified as priority
- Scalable geriatric-HIV care models needed for growing aging HIV population
- People with perinatal HIV face unique aging challenges requiring targeted research
Methodology
This was a workshop summary rather than an experimental study. The 15th Annual International Workshop on Aging and HIV was held October 24-25, 2024, featuring keynote presentations and expert discussions on aging mechanisms, clinical manifestations, and care models.
Study Limitations
This represents expert consensus from a workshop rather than new experimental data. Implementation strategies require validation across diverse populations and healthcare systems. The findings are specific to HIV-aging intersection but may not generalize to other aging populations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.